Skip to main content

Swiss National Bank

Bank

Position in KNSA — Kiniksa Pharmaceuticals International, plc

CIK 1582202 ZURICH, V8

Position in KNSA

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$4,713,115
+$1,270,390 QoQ
Shares Held
73,700
+3.1% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#63
of 266 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KNSA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Swiss National Bank holds $505,151,346 across 28 Drug Manufacturers - Specialty & Generic names. KNSA ranks #14 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KNSA

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,713,115 73,700
2026-03-31 $3,442,725 71,500
2025-12-31 $2,829,750 68,600
2025-09-30 $2,551,131 65,700
2025-06-30 $1,787,482 64,600
2025-03-31 $1,596,899 71,900
2024-12-31 $1,422,182 71,900
2024-09-30 $1,964,214 78,600
2024-06-30 $1,467,462 78,600